NRx Pharmaceuticals, Inc.
NRXP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,890 | -$17,580 | -$5,512 | -$9,078 |
| Dep. & Amort. | $41 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $67 | $12 | $0 |
| Change in WC | $567 | -$516 | $0 | $548 |
| Other Non-Cash | $2,391 | $14,001 | $2,020 | $7,065 |
| Operating Cash Flow | -$2,891 | -$4,028 | -$3,480 | -$1,464 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | -$2,561 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,561 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$225 | $378 | $4,680 | $3,320 |
| Stock Issued | $9,952 | $1,012 | $3,255 | -$2,059 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $0 | -$350 | $0 |
| Financing Cash Flow | $9,726 | $1,390 | $7,585 | $1,261 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,274 | -$2,638 | $4,105 | -$203 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,910 | $5,548 | $1,443 | $1,646 |
| End Cash | $7,184 | $2,910 | $5,548 | $1,443 |
| Free Cash Flow | -$2,891 | -$4,028 | -$3,480 | -$1,464 |